Safety of rituximab in rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at increased risk of manifestations such as serious infectious events (SIEs), malignancies and cardiovascular disease (1). Moreover, a long administration of drugs is required in this chronic disease, a condition that is responsible of a greater risk of si...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PAGEPress Publications
2011-06-01
|
| シリーズ: | Reumatismo |
| オンライン･アクセス: | http://www.reumatismo.org/index.php/reuma/article/view/470 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|